Form 8-K - Current report:
SEC Accession No. 0001437749-21-006339
Filing Date
2021-03-17
Accepted
2021-03-17 16:36:53
Documents
3
Period of Report
2021-03-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dffn20210317_8k.htm 8-K 27139
2 EXHIBIT 99.1 ex_234803.htm EX-99.1 25119
3 img.jpg GRAPHIC 7965
  Complete submission text file 0001437749-21-006339.txt   64774
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 21751038
SIC: 2834 Pharmaceutical Preparations